Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 112

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 112
---
 or dissenters’ rights are available to Aadi stockholders under the DGCL or under Aadi’s certificate of incorporation or bylaws in connection with the Divestiture Agreement.

- 72 -

THE DIVESTITURE AGREEMENT

The following summary describes the material provisions of the Divestiture Agreement. The descriptions of the Divestiture Agreement in this summary and elsewhere in this proxy statement are not complete and are qualified in their entirety by reference to the Divestiture Agreement, a copy of which is attached to this proxy statement as Annex A and incorporated into this proxy statement by reference. We encourage you to carefully read and consider the Divestiture Agreement, which is the legal document that governs the Divestiture, in its entirety because this summary may not contain all the information about the Divestiture Agreement that is important to you.The rights and obligations of theparties are governed by the express terms ofthe Divestiture Agreement, and not by this summary or any other information contained in this proxy statement.

The representations, warranties, covenants and agreements described below and included in the Divestiture Agreement (1) were made only for purposes of the Divestiture Agreement and as of specific dates; (2) were made solely for the benefit of the parties to the Divestiture Agreement; (3) may be subject to important qualifications, limitations and supplemental information agreed to by Aadi, Aadi Sub, Kaken Parent and Kaken in connection with negotiating the terms of the Divestiture Agreement; and (4) may also be subject to a contractual standard of materiality different from those generally applicable to reports and documents filed with the SEC and in some cases were qualified by confidential matters disclosed by Aadi and Aadi Sub to Kaken in connection with the Divestiture Agreement. In addition, the representations, warranties, covenants and agreements may have been included in the Divestiture Agreement for the purpose of allocating contractual risk between Aadi, Aadi Sub and Kaken rather than to establish matters as facts. Further, the representations and warranties were negotiated with the principal purpose of establishing the circumstances in which a party to the Divestiture Agreement may have the right to terminate the Divestiture Agreement if the representations and warranties of the other party prove to be untrue due to a change in circumstance or otherwise, or the covenants and agreements of the other party are breached, and the circumstances in which Kaken may be entitled to indemnification from Aadi if the representations and warranties of Aadi prove to be